Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

TherapeuticsMD Q3 EPS $(0.05) Up From $(0.13) YoY, Sales $547.00K Up From $(53.00K) YoY

Author: Benzinga Newsdesk | November 12, 2024 05:25pm
TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.05) per share. This is a 61.54 percent increase over losses of $(0.13) per share from the same period last year. The company reported $547.00 thousand in sales this quarter. This is a 1.13K percent increase over sales of $(53.00 thousand) the same period last year.

Posted In: TXMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist